sr 48692 has been researched along with dactinomycin in 1 studies
| Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
|---|---|---|---|---|---|
| 203 | 3 | 36 | 19,045 | 355 | 969 |
| Protein | Taxonomy | sr 48692 (IC50) | dactinomycin (IC50) |
|---|---|---|---|
| RAD51 | Homo sapiens (human) | 32.1 | |
| Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
| Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, H; Dong, Z; Ke, XX; Lei, Q; Yang, L; Yang, R; Yi, L; Zhu, S | 1 |
1 other study(ies) available for sr 48692 and dactinomycin
| Article | Year |
|---|---|
Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma.
Topics: 3' Untranslated Regions; Animals; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Cell Line, Tumor; Cytochromes c; Dactinomycin; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Knockdown Techniques; Glioblastoma; Humans; Membrane Potential, Mitochondrial; Mice; Mice, Nude; MicroRNAs; Mitochondria; Neoplasm Transplantation; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Quinolines; Receptors, Neurotensin; RNA, Small Interfering; Up-Regulation | 2017 |